Vanda Pharmaceuticals

This early-stage study is testing the safety of a drug called trichostatin A in people with blood cancers that have returned or not responded to standard treatments. About 42 adults will receive the drug to find the best dose and see what side effects occur. The goal is to see if…

This study tests if the drug iloperidone can lower blood pressure in people whose high blood pressure is not controlled by their current medications. About 240 adults will receive either iloperidone or a placebo for 4 weeks. The main goal is to see if the drug safely reduces sitt…

This study tests whether a long-acting injection of iloperidone can prevent schizophrenia symptoms from getting worse compared to a placebo. About 400 adults aged 18 to 65 with schizophrenia will receive either the drug or a placebo injection. The main goal is to see how long it …

This study tests whether adding milsaperidone to standard antidepressant treatment can better reduce depression symptoms in adults who haven't improved enough with current medication. About 500 participants will receive either milsaperidone or a placebo, and their depression seve…

This study tests a single-dose pill called VQW-765 to see if it can quickly reduce sudden anxiety in people with social anxiety disorder. About 500 adults will receive either the drug or a placebo before a stressful social task. The goal is to measure distress levels during and b…

This study tests whether tradipitant can reduce nausea and vomiting caused by GLP-1 weight-loss drugs (like Ozempic or Wegovy). About 280 healthy overweight or obese adults will receive either tradipitant or a placebo. The main goal is to see if tradipitant lowers the number of v…

This study tests whether a daily pill called tasimelteon can help people with delayed sleep-wake phase disorder fall asleep earlier and sleep better. About 70 adults aged 18-75 with this condition will receive either the drug or a placebo. The goal is to improve sleep timing and …